GN Store Nord
Health Care Equipment
Denmark
ESRS disclosure: E2-1_02
Tags Tree
Selected: 0
No matching results found.
- Does the undertaking's policy address substituting and minimizing the use of substances of concern, and phasing out substances of very high concern, particularly for non-essential societal use and in consumer products, within its own operations and its upstream and downstream value chain?
-
Question Id: E2-1_02
GN’s Environmental Policy includes commitments to substitute or reduce the use of hazardous substances in our own operations and value chain wherever possible. Current and planned actions are undertaken within the parameters of our existing product development programs, financial planning, and business model. For products for which we depend on outsourced manufacturing, the focus is on phasing out halogens, specifically bromine, choline, and fluorine. For Jabra products, requirements for suppliers and verification compliance through in-house testing are set. The phase-out of bromine and chlorine is expected in 2025, and fluorine by 2026 for the same parts.
Report Date: 4Q2024Relevance: 85%